Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
Add more filters

Country/Region as subject
Affiliation country
Publication year range
1.
World J Surg ; 43(2): 476-485, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30242456

ABSTRACT

BACKGROUND: Pelvic fracture with hypovolemic shock is a known crucial injury in trauma patients. Pelvic fracture with vessel injury often leads to hemodynamic complications; in a trauma scenario, evidence of other systems being affected is often absent. Bleeding cessation and resuscitation are important for these types of trauma patients. For this purpose, pelvic angiographic embolization is frequently used. Multiple studies have reported that angiographic embolization may cause erectile dysfunction (ED) in hemodynamically stable patients with pelvic fracture. However, no study has evaluated a large patient cohort with a long-term follow-up. We hypothesized that angiographic embolization to control bleeding may compromise blood supply to the genitourinary organs or cause secondary neurogenic injury that increases the risk of ED. Our goal was to evaluate the risk of ED following pelvic fractures in male patients treated with pelvic angiographic embolization. METHODS: We used data from the National Health Insurance Research Database (NHIRD) from 1997 to 2010 provided by the Bureau of National Health Insurance of the Department of Health in Taiwan. We collected disease histories from inpatient files. The disease diagnoses were based on the International Classification of Diseases (ICD), Ninth Revision, Clinical Modification. These data were all deidentified, and we did not contact the patients. As such, informed consent was not needed. RESULTS: Eighty-five and 82,802 patients were included in the case and control cohorts, respectively. All patients were aged 15-45, and the proportion of pelvic fracture locations was equal between the groups. After investigating the causes of ED among male patients aged 15-45 with pelvic fractures using logistic regression analysis in a generalized estimating equations model and after adjusting for the influence of confounders, we found that these patients had high risks (odds ratio (OR): 32.637; 95% confidence interval: 14.137-75.346; P < 0.001) of developing ED post-angiographic embolization. CONCLUSIONS: Male patients in Taiwan with pelvic fractures who undergo angiographic embolization to control bleeding have a higher risk of ED than those who do not undergo the procedure. Physicians should practice caution and inform patients of this connection before the procedure.


Subject(s)
Embolization, Therapeutic/adverse effects , Erectile Dysfunction/etiology , Fractures, Bone/complications , Hemorrhage/therapy , Pelvic Bones/injuries , Adolescent , Adult , Angiography/adverse effects , Angiography/statistics & numerical data , Case-Control Studies , Cohort Studies , Databases, Factual/statistics & numerical data , Embolization, Therapeutic/methods , Embolization, Therapeutic/statistics & numerical data , Erectile Dysfunction/epidemiology , Fractures, Bone/epidemiology , Hemorrhage/etiology , Humans , Male , Middle Aged , Taiwan/epidemiology , Young Adult
2.
Surg Today ; 49(3): 261-267, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30302552

ABSTRACT

The trauma team leader is a professional who receives and treats trauma patients. We aimed to evaluate whether or not the seniority of a qualified trauma team leader was a prognostic factor for multiple-trauma patients managed by a trauma team. This was a retrospective cohort study conducted at a Level I Trauma Center in North Taiwan. From January 2009 to December 2013, 284 patients were randomly assigned to one of two trauma team leaders (junior and senior leaders) on duty, irrespective of the seniority of the qualified trauma team leader. All parameters were collected and compared between these two groups. In the subgroup of multiple-trauma patients with Glasgow Coma Scale (GCS) ≤ 8, there were significant differences in the injury severity score, revised trauma score, and seniority of the leader between the alive and dead groups. A multivariate logistic regression analysis showed that the seniority of the trauma team leader was an important mortality risk factor [odds ratio (OR): 14.529, 95% confidence interval (CI) 1.683-125.429, p = 0.015] in patients with GCS ≤ 8. However, in patients with GCS > 8, age was the only independent risk factor [OR: 1.055, 95% CI 1.023-1.087, p = 0.001]. The seniority of the qualified trauma leader is important for teamwork, organization, and efficiency, all of which play an important role in improving the survival outcome of patients with GCS ≤ 8.


Subject(s)
Craniocerebral Trauma/mortality , Craniocerebral Trauma/therapy , Leadership , Patient Care Team/statistics & numerical data , Trauma Centers/statistics & numerical data , Adult , Cohort Studies , Female , Humans , Male , Multivariate Analysis , Physician's Role , Regression Analysis , Retrospective Studies , Risk Factors , Survival Rate , Taiwan/epidemiology , Trauma Severity Indices
3.
Surg Today ; 47(12): 1443-1449, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28434082

ABSTRACT

PURPOSES: Researchers studying trauma have found that physicians are able to perform a focused assessment with sonography for trauma (FAST) with minimal training and achieve ideal accuracy. However, there are currently no consensus or standard guidelines regarding the performance of this assessment. The aim of our study was to clarify the value of FAST performed by well-qualified senior general surgery residents in cases of suspected blunt abdominal trauma, which presents an important diagnostic problem in emergency departments. METHODS: This was a retrospective study in the emergency department (ED) of our hospital performed from January 2011 to September 2013. Patients were included if they (1) had undergone a FAST examination performed by qualified residents and (2) had received subsequent formal radiographic or surgical evaluations. The results were compared against subsequent surgical findings or formal Department of Radiology reference standards. RESULTS: Among the 438 patients enrolled, false-negative results were obtained in 8 and false-positive results in 5. Only one patient was missed and required laparotomy to repair a small intestine perforation. The sensitivity and specificity were 87 and 99%, respectively; the accuracy was 97%. CONCLUSIONS: Senior general surgery residents can be trained to perform accurate FAST examinations on trauma patients.


Subject(s)
Abdominal Injuries/diagnostic imaging , Emergency Service, Hospital , General Surgery/education , Internship and Residency , Surgeons/education , Ultrasonography , Wounds, Nonpenetrating/diagnostic imaging , Adult , Clinical Competence , Diagnostic Errors/statistics & numerical data , Female , Humans , Male , Middle Aged , Retrospective Studies , Sensitivity and Specificity , Young Adult
4.
World J Surg Oncol ; 12: 80, 2014 Mar 31.
Article in English | MEDLINE | ID: mdl-24684952

ABSTRACT

BACKGROUND: Findings related to the influence of the -160C → A promoter polymorphism and haplotypes of the E-cadherin (CDH1) gene have not been consistent in previous studies regarding the risk for sporadic gastric cancer. Investigators in most previous studies detected those genotypes using restriction fragment length polymorphism analysis. Therefore, we conducted a case-control study to investigate the association of the CDH1 - 160C → A promoter polymorphism and haplotypes for cancer risk related to sporadic diffuse and intestinal gastric cancer by direct sequencing analysis. METHODS: We included 107 diffuse gastric cancer cases, 60 intestinal gastric cancer cases and 134 controls. The genotypic polymorphisms in the -160 promoter region, exons and intron-exon boundaries of CDH1 were detected by direct sequencing analysis. Genotype frequencies were compared. The CDH1 - 160C → A promoter polymorphism and four polymorphisms (48 + 6 T → C, 2076C → T, 2253C → T and 1937-13 T → C) were included in the haplotype analyses, which were estimated using the expectation-maximization algorithm. RESULTS: Compared to controls, the frequency of the -160A allele was significantly higher in diffuse gastric cancer cases (P = 0.005), but it was not significantly different in intestinal gastric cancer cases (P = 0.119). Two sets of three-marker haplotypes (-160C → A, 48 + 6 T → C, 2076C → T and -160C → A, 1937-13 T → C, 2253C → T) were associated with the risk of diffuse gastric cancer (P = 0.011 and P = 0.042, respectively). CONCLUSION: Based on direct sequencing analysis, our findings suggest that the CDH1 - 160C → A promoter polymorphism and haplotypes play significant roles in cancer risk for sporadic diffuse gastric cancer, but not for intestinal gastric cancer, in a Taiwanese population.


Subject(s)
Biomarkers, Tumor/genetics , Cadherins/genetics , Haplotypes/genetics , Intestinal Neoplasms/genetics , Polymorphism, Single Nucleotide/genetics , Stomach Neoplasms/genetics , Adult , Aged , Aged, 80 and over , Antigens, CD , Cadherins/metabolism , Case-Control Studies , Female , Follow-Up Studies , Genetic Predisposition to Disease , Genotype , Humans , Immunoenzyme Techniques , Intestinal Neoplasms/pathology , Male , Middle Aged , Neoplasm Staging , Prognosis , Promoter Regions, Genetic/genetics , Sequence Analysis, DNA , Stomach Neoplasms/pathology , Young Adult
5.
Hepatogastroenterology ; 60(121): 140-3, 2013.
Article in English | MEDLINE | ID: mdl-23841121

ABSTRACT

BACKGROUND/AIMS: Intra-peritoneal lavage is well known and used in intra-peritoneal malignancy However, the clinical role for patients with rupture of HCC has not yet been established. The aim of this study was to evaluate the clinical value of intraoperative peritoneal lavage for patients with rupture of HCC. METHODOLOGY: A retrospective study of operative findings, other factors, and outcome was performed in 66 patients with rupture of HCC who underwent distilled water peritoneal lavage (DWPL) during hepatectomy. RESULTS: There was a trend towards a higher intra-peritoneal, extra-hepatic recurrence rate in patients without DWPL. Patients who underwent DWPL had a significantly better 5-year disease-free survival rate than control group, 11.5±4.6 months and 30.2±8.4 months (p=0.018), respectively, and better overall survival rate, 21.7±6.2 months, than control group, 57.3±11.2 months (p=0.001). CONCLUSIONS: DWPL during liver resection retards tumor recurrence and improves the intraoperative survival rate in patients with spontaneously ruptured HCC.


Subject(s)
Carcinoma, Hepatocellular/therapy , Liver Neoplasms/therapy , Peritoneal Lavage , Adult , Aged , Carcinoma, Hepatocellular/mortality , Distillation , Female , Humans , Liver Neoplasms/mortality , Male , Middle Aged , Retrospective Studies , Rupture, Spontaneous , Survival Rate , Water
6.
J Cell Physiol ; 227(1): 213-22, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21391217

ABSTRACT

Drug resistance frequently develops in tumors during chemotherapy. Therefore, to improve the clinical outcome, more effective and tolerable combination treatment strategies are needed. Here, we show that isochaihulactone (K8) enhanced paclitaxel-induced apoptotic death in human lung cancer cells, and the enhancing effect was related to increased NSAID-activated gene-1 (NAG-1) expression. CalcuSyn software was used to evaluate the synergistic interaction of K8 and paclitaxel on human lung cancer cells; the synergistic effect of K8 in combination with paclitaxel was increased more than either of these drugs alone. Furthermore, the activity of ERK1/2 was enhanced by the combination of K8 and paclitaxel, and an ERK1/2 inhibitor dramatically inhibited NAG-1 expression in human lung cancer cells. Therefore, this synergistic apoptotic effect in human lung cancer cells may be directly associated with K8-induced NAG-1 expression through ERK1/2 activation. Moreover, over-expression of NAG-1 enhanced K8/paclitaxel-induced apoptosis in human lung cancer cells. In addition, treatment of nude mice with K8 combined with paclitaxel induced phospho-ERK1/2 and NAG-1 expression in vivo. Targeting of NAG-1 signaling could enhance therapeutic efficacy in lung cancer. Our results reveal that activation of NAG-1 by K8 enhanced the therapeutic efficacy of paclitaxel in human lung cancer cells via the ERK1/2 signaling pathway.


Subject(s)
4-Butyrolactone/analogs & derivatives , Adenocarcinoma/metabolism , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Benzodioxoles/pharmacology , Lung Neoplasms/metabolism , Paclitaxel/pharmacology , 4-Butyrolactone/pharmacology , Adenocarcinoma/pathology , Apoptosis/drug effects , Blotting, Western , Cell Line, Tumor , Cell Proliferation/drug effects , Drug Synergism , Growth Differentiation Factor 15/metabolism , Humans , Immunohistochemistry , Lung Neoplasms/pathology , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/physiology
7.
Onkologie ; 35(3): 114-7, 2012.
Article in English | MEDLINE | ID: mdl-22414975

ABSTRACT

BACKGROUND: Perivascular epithelioid cell tumors (PEComas) are very rare mesenchymal neoplasms, and have been found in various organs such as the liver, kidney, falciform ligament, uterus, uterine cervix, and both the small and large bowel. However, only 3 cases of mesenteric PEComa have been described in the literature so far. The treatment and prognosis of malignant mesenteric PEComas are discussed. CASE REPORT: We report the case of a 59-year-old man diagnosed with PEComa. He underwent segmental resection of the jejunum and tumor resection. Malignant mesenteric PEComa was confirmed on the basis of clinicopathological features. Tumor resection was followed by concurrent chemoradiotherapy. CONCLUSION: Besides surgery, no effective treatment for malignant PEComa has been established thus far because of the rarity of this tumor. Here, we report our experience of treating a malignant mesenteric PEComa using surgery and subsequent adjuvant therapy, which effectively controlled disease progression and prevented local recurrence.


Subject(s)
Epithelioid Cells/pathology , Jejunal Neoplasms/diagnosis , Mesentery/pathology , Peritoneal Neoplasms/diagnosis , Perivascular Epithelioid Cell Neoplasms/diagnosis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chemoradiotherapy , Combined Modality Therapy , Diagnosis, Differential , Follow-Up Studies , Humans , Jejunal Neoplasms/drug therapy , Jejunal Neoplasms/radiotherapy , Jejunal Neoplasms/surgery , Male , Middle Aged , Neoplasm Recurrence, Local/drug therapy , Peritoneal Neoplasms/drug therapy , Peritoneal Neoplasms/radiotherapy , Peritoneal Neoplasms/surgery , Perivascular Epithelioid Cell Neoplasms/drug therapy , Perivascular Epithelioid Cell Neoplasms/radiotherapy , Perivascular Epithelioid Cell Neoplasms/surgery , Salvage Therapy , Tomography, X-Ray Computed
8.
Article in English | MEDLINE | ID: mdl-23049612

ABSTRACT

Lung cancer is one of the leading causes of cancer death in worldwide and required for novel therapeutic strategy. Our previous research demonstrated that the crude acetone extract of Bupleurum scorzonerifolium (BS-AE) and its component isochaihulactone induce antiproliferative and apoptotic effects on the lung adenocarcinoma cell line. Structural analysis has identified isochaihulactone as a lignan, with a chiral center and two racemic forms (Z-isochaihulactone and E-isochaihulactone). In this study, Z-isochaihulactone displayed significantly higher tumor cytotoxicity than E-isochaihulactone in A549 cells. The notch signaling pathway plays a pivotal role in determination of cell fate during development, while in lung cancer, it might have oncogenic or tumor-suppressive controversial functions. We showed that Z-isochaihulactone induced morphological changes in the A549 cells, inhibited cell growth, and arrested the cell cycle at the G2/M phase. It also induced upregulation of the active form of Notch1 (notch intracellular domain, NICD), which further induced p21 and c-Myc expression in time- and dose-dependent manners. Administrations of Z-isochaihulactone in nude mice can significantly inhibit tumor growth due to enhancement of NICD expression confirmed by immunohistochemical analysis. Taken together, our results supported that Z-isochaihulactone can efficiently inhibit tumorigenicity and be a potential compound for therapy.

10.
J Pers Med ; 12(2)2022 Feb 18.
Article in English | MEDLINE | ID: mdl-35207798

ABSTRACT

Patients who undergo splenectomy are at a high risk of infection. We aimed to investigate the rate of pneumonia in patients who underwent splenectomy, specifically comparing those who had splenectomy due to spleen injury and those who had it for other reasons. A population-based cohort study was conducted. Overall, 17,498 patients who underwent splenectomy between 2000 and 2015 were enrolled, including 11,817 patients with a history of spleen injury and 5681 controls without spleen injury. The incidence of pneumonia was calculated at the end of 2016. A multivariable Cox proportional hazards regression model was used to compare the hazard ratio with 95% CI for pneumonia associated with the spleen injury-caused splenectomy and splenectomy due to other causes. The crude HR for patients with splenectomy due to spleen injury to develop pneumonia was 1.649. After adjusting for covariates, the adjusted hazard ratio was 1.567. There were statistically significant differences in all subgroups, except for the group with a tracking duration >10 years. We found an increase in pneumonia risk in the 'spleen injury' group when comparing it to that of the 'other causes' group, regardless of age, sex, and area of residence.

11.
Am J Physiol Cell Physiol ; 300(3): C406-15, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21123732

ABSTRACT

Matriptase, a type 2 transmembrane serine protease, and its inhibitor hepatocyte growth factor activator inhibitor (HAI)-1 are required for normal epidermal barrier function, and matriptase activity is tightly regulated during this process. We therefore hypothesized that this protease system might be deregulated in skin disease. To test this, we examined the level and activation state of matriptase in examples of 23 human skin disorders. We first examined matriptase and HAI-1 protein distribution in normal epidermis. Matriptase was detected at high levels at cell-cell junctions in the basal layer and spinous layers but was present at minimal levels in the granular layer. HAI-1 was distributed in a similar pattern, except that high-level expression was retained in the granular layer. This pattern of expression was retained in most skin disorders. We next examined the distribution of activated matriptase. Although activated matriptase is not detected in normal epidermis, a dramatic increase is seen in keratinocytes at the site of inflammation in 16 different skin diseases. To gain further evidence that activation is associated with inflammatory stimuli, we challenged HaCaT cells with acidic pH or H(2)O(2) and observed matriptase activation. These findings suggest that inflammation-associated reactive oxygen species and tissue acidity may enhance matriptase activation in some skin diseases.


Subject(s)
Dermatitis/enzymology , Dermatitis/pathology , Inflammation Mediators/metabolism , Serine Endopeptidases/metabolism , Cell Line, Transformed , Dermatitis/metabolism , Down-Regulation/physiology , Enzyme Activation/physiology , Epidermis/enzymology , Epidermis/metabolism , Epidermis/pathology , Epithelial Cells/enzymology , Epithelial Cells/ultrastructure , Humans , Inflammation Mediators/physiology , Intercellular Junctions/enzymology , Intercellular Junctions/metabolism , Intercellular Junctions/ultrastructure , Keratinocytes/enzymology , Keratinocytes/ultrastructure , Proteinase Inhibitory Proteins, Secretory/metabolism , Proteinase Inhibitory Proteins, Secretory/physiology , Serine Proteinase Inhibitors/metabolism , Serine Proteinase Inhibitors/pharmacology , Up-Regulation/physiology
12.
Medicine (Baltimore) ; 99(31): e21182, 2020 Jul 31.
Article in English | MEDLINE | ID: mdl-32756096

ABSTRACT

The implementation of electronic medical records (EMRs) has generally been thought to improve medical efficiency and safety, but consistent evidence of improved healthcare quality due to EMRs in population-based studies is lacking. We assessed the relationship between the degree of EMR adoption and patient outcomes.We performed an observational study using discharge data from Tri-service General Hospital from 2013 to 2018. The levels of EMR utilization were divided into no EMRs, partial EMRs and full EMRs. The primary healthcare quality indicators were inpatient mortality, readmission within 14 days, and 48-hour postoperative mortality. We performed a Cox proportional hazards regression analysis to evaluate the relationship between the EMR utilization level and healthcare quality.In total, 262,569 patients were included in this study. Compared with no EMRs, full EMR implementation led to lower inpatient mortality [adjusted hazard ratio (HR) 0.947, 95% confidence interval (CI): 0.897-0.999, P = ..049] and a lower risk of readmission within 14 days (adjusted HR 0.627, 95% CI: 0.577-0.681, P < .001). Full EMR implementation was associated was a lower risk of 48-hour postoperative mortality (adjusted HR 0.372, 95% CI: 0.208-0.665, P = .001) than no EMRs. Partial EMR implementation was associated with a higher risk of readmission within 14 days than no EMRs (HR 1.387, 95% CI: 1.298-1.485, P < .001).Full EMR adoption improves healthcare quality in medical institutions treating severely ill patients. A prospective study is needed to confirm this finding.


Subject(s)
Benchmarking , Electronic Health Records/standards , Patient Discharge , Quality of Health Care , Humans , Proportional Hazards Models , Taiwan
13.
Am J Physiol Cell Physiol ; 297(2): C459-70, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19535514

ABSTRACT

Matriptase, a transmembrane serine protease, is broadly expressed by, and crucial for the integrity of, the epithelium. Matriptase is synthesized as a zymogen and undergoes autoactivation to become an active protease that is immediately inhibited by, and forms complexes with, hepatocyte growth factor activator inhibitor (HAI-1). To investigate where matriptase is activated and how it is secreted in vivo, we determined the expression and activation status of matriptase in seminal fluid and urine and the distribution and subcellular localization of the protease in the prostate and kidney. The in vivo studies revealed that while the latent matriptase is localized at the basolateral surface of the ductal epithelial cells of both organs, only matriptase-HAI-1 complexes and not latent matriptase are detected in the body fluids, suggesting that activation, inhibition, and transcytosis of matriptase would have to occur for the secretion of matriptase. These complicated processes involved in the in vivo secretion were also observed in polarized Caco-2 intestinal epithelial cells. The cells target latent matriptase to the basolateral plasma membrane where activation, inhibition, and secretion of matriptase appear to take place. However, a proportion of matriptase-HAI-1 complexes, but not the latent matriptase, appears to undergo transcytosis to the apical plasma membrane for secretion. When epithelial cells lose their polarity, they secrete both latent and activated matriptase. Although most epithelial cells retain very low levels of matriptase-HAI-1 complex by rapidly secreting the complex, gastric chief cells may activate matriptase and store matriptase-HAI-1 complexes in the pepsinogen-secretory granules, suggesting an intracellular activation and regulated secretion in these cells. Taken together, while zymogen activation and closely coupled HAI-1-mediated inhibition are common features for matriptase regulation, the cellular location of matriptase activation and inhibition, and the secretory route for matriptase-HAI-1 complex may vary along with the functional divergence of different epithelial cells.


Subject(s)
Cell Polarity , Enzyme Precursors/metabolism , Epithelial Cells/metabolism , Proteinase Inhibitory Proteins, Secretory/metabolism , Serine Endopeptidases/metabolism , Animals , Body Fluids/enzymology , Cell Line , Enzyme Activation , Epithelial Cells/cytology , Female , Humans , Kidney/cytology , Kidney/enzymology , Male , Prostate/cytology , Prostate/enzymology , Stomach/cytology , Stomach/enzymology
14.
Acta Pharmacol Sin ; 30(9): 1297-306, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19701232

ABSTRACT

AIM: To investigate the role of hTERT gene expression and AP-2alpha in n-butylidenephthalide (n-BP)-induced apoptosis in A549 lung cancer cells. METHODS: Viability of A549 cells was measured by MTT assay. Protein expression was determined by Western blot. Telomerase activity was measured using the modified telomere repeat amplification protocol (TRAP) assay. Xenograft mice were used as a model system to study the cytotoxic effect of n-BP in vivo. The morphology of tumor was examined by immunohistochemical staining. RESULTS: The growth of A549 lung cancer cells treated with n-BP was significantly inhibited. Telomerase activity and hTERT mRNA expression were determined by telomeric repeat amplification protocol and reverse transcription-polymerase chain reaction, respectively. n-BP inhibited telomerase activity and hTERT mRNA expression in A549 cells while overexpression of hTERT could abolish BP-induced growth inhibition in the A549 cells. We also showed that hTERT promoter activity in the presence of n-BP was mediated via AP-2alpha. We saw an inhibition of tumor growth when nude mice carrying A549 subcutaneous xenograft tumors were treated with n-BP. Immunohistochemistry of this tumor tissue also showed a decrease in the expression of hTERT. CONCLUSION: The antiproliferative effects of n-BP on A549 cells in vitro and in vivo suggest a novel clinical application of this compound in the treatment of lung cancers.


Subject(s)
Adenocarcinoma/genetics , Apoptosis/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Lung Neoplasms/genetics , Phthalic Anhydrides/pharmacology , Telomerase/metabolism , Transcription Factor AP-2/drug effects , Adenocarcinoma/enzymology , Animals , Blotting, Western , Down-Regulation/drug effects , Gene Expression Regulation, Neoplastic/genetics , Humans , Lung Neoplasms/enzymology , Mice , RNA, Neoplasm/genetics , Reverse Transcriptase Polymerase Chain Reaction , Telomerase/drug effects , Telomerase/genetics , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
15.
World J Surg ; 33(12): 2679-82, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19771471

ABSTRACT

BACKGROUND: Various types of incisions have been applied in simultaneous resections of colorectal cancer and synchronous liver metastases. We describe our experience with the reversed L-shaped incision for simultaneous right hemicolectomy and liver resection. METHODS: We applied the reversed L-shaped incision in nine patients who underwent simultaneous right hemicolectomy and right liver resection or left hepatectomy. A reversed L-shaped incision of the abdomen was consisted of midline and transverse incisions with the junction of the umbilicus. The operative field was kept open using Kent retractors. First, right colon mobilization was performed easily and right hemicolectomy was performed. Subsequently, liver mobilization with identification of hepatic vessels was achieved and right liver resection or left hepatectomy was performed. RESULTS: The reversed L-shaped incision successfully provided a good and rapid exposure in nine patients. There were no complications, such as wound infection, lung atelectasis/pneumonia, or incisional hernia, in patients with the reversed L-shaped incision. CONCLUSIONS: Our preliminary experience demonstrated that the reversed L-shaped incision might be a good choice in a subset of patients with simultaneous right hemicolectomy and right liver resection or left hepatectomy. However, a large, prospective, controlled study comparing different incision types in the same procedure with variables, such as operating time, postoperative pain scores, patient's satisfaction, and postoperative complication, is needed to support the benefit of the reversed L-shaped incision.


Subject(s)
Colectomy/methods , Colorectal Neoplasms/surgery , Hepatectomy/methods , Liver Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/pathology , Female , Humans , Liver Neoplasms/secondary , Male , Middle Aged , Retrospective Studies
16.
Hepatogastroenterology ; 56(89): 133-8, 2009.
Article in English | MEDLINE | ID: mdl-19453044

ABSTRACT

BACKGROUND/AIMS: Esophageal transection in the Modified Sugiura procedure is advocated by some authors, but considered unnecessary by others. We compared the effectiveness of the Modified Sugiura procedure to our simplified Sugiura procedure that omits esophageal transection for the emergency treatment of bleeding esophagogastric varices. METHODOLOGY: From January 1999 to September 2004 we treated 51 patients with cirrhosis of the liver and bleeding esophagogastric varices. All patients had failed management with emergency endoscopy treatment or balloon tamponade with vasopressin infusion. The patients were randomly divided into two groups and underwent the Modified Sugiura procedure with or without esophageal transections. RESULTS: There were no significant differences in age, gender, cause of cirrhosis, or Child-Pugh classification between the two groups. The preoperative hemoglobin levels, preoperative and intraoperative transfusion volume, mortality, morbidity, and days of hospitalization showed no significant differences between the groups. The operative time was shorter with the simplified Sugiura procedure. The 1-3 year survival rates and the rebleeding rates did not differ significantly between the two groups. CONCLUSION: Both treatments are effective emergency procedures for bleeding esophagogastric varices. Our simplified Sugiura procedure is an effective treatment for bleeding esophagogastric varices and requires a shorter operating time than the Modified Sugiura procedure.


Subject(s)
Esophageal and Gastric Varices/surgery , Gastrointestinal Hemorrhage/surgery , Anastomosis, Surgical , Blood Transfusion/statistics & numerical data , Esophageal and Gastric Varices/complications , Esophagus/surgery , Female , Gastrointestinal Hemorrhage/etiology , Humans , Length of Stay/statistics & numerical data , Liver Cirrhosis/complications , Male , Middle Aged , Postoperative Complications , Splenectomy , Statistics, Nonparametric , Survival Rate , Time Factors , Treatment Outcome
17.
Medicine (Baltimore) ; 98(18): e15457, 2019 May.
Article in English | MEDLINE | ID: mdl-31045819

ABSTRACT

A mass casualty incident (MCI) can have an enormous impact on an already crowded emergency department (ED), affecting the quality of health care provided to non-MCI ED patients. On June 26, 2015, a burn MCI (BMCI) occurred due to a cornstarch explosion at a party at a water park. The competing needs of the BMCI patients might have crowded out the needs of the non-BMCI patients. Although crowd-out effects have been previously documented in a variety of health care situations, they have not been extensively evaluated during MCIs. We aimed to determine whether the outcomes of the non-MCI patients were compromised during this incident.We conducted a retrospective observational study comparing several health care parameters and outcomes between non-BMCI patients and historical controls during the designated period using institutional electronic records and the National Health Insurance Research Database.On the night of the incident, 53 patients were sent to our ED; most of them arrived within 3 hours after the BMCI. There was a significant increase in the wait time for ICU beds among non-BMCI patients compared to the wait times during the corresponding week of the previous year (8.09 ±â€Š4.21 hours vs 3.77 ±â€Š2.15 hours, P = .008). At the hospital level, there was a significantly increased length of hospital stay (LOS) in the ICU after the MCI compared with the LOS in the ICU in the same week of the preceding year (median days: 15 vs 8, P ≤ .001). At the regional level, there were no significant differences between the 2 periods in the LOS in acute care, LOS in the ICU or mortality rates at the involved medical centers.Crowd-out effects from the MCI occurred in the ED and at the institutional level. Although there was an increased wait time for admission to the ICU and a longer LOS in the ICU, the LOS in acute care beds, treatment of time-sensitive diseases, and mortality rates were not compromised by the current MCI protocol at either the institutional or regional levels.


Subject(s)
Blast Injuries/mortality , Burns/mortality , Crowding , Explosions/history , Mass Casualty Incidents/statistics & numerical data , Blast Injuries/etiology , Blast Injuries/history , Burns/etiology , Burns/history , Critical Care/statistics & numerical data , Dust , Emergency Service, Hospital/statistics & numerical data , Female , History, 21st Century , Hospital Mortality , Hospitalization/statistics & numerical data , Humans , Intensive Care Units/statistics & numerical data , Male , Mass Casualty Incidents/history , Multiple Trauma/etiology , Multiple Trauma/history , Multiple Trauma/mortality , Retrospective Studies , Taiwan/epidemiology , Triage/statistics & numerical data
18.
J Gastrointest Surg ; 23(10): 2049-2053, 2019 10.
Article in English | MEDLINE | ID: mdl-30298416

ABSTRACT

BACKGROUND: Laparoscopic surgery is the main trend method in a variety of surgical fields. Post-operative shoulder pain remains a bothersome issue although many surgical techniques have been applied to minimize it. A simple novel approach to reduce shoulder pain without adverse effects during and after laparoscopic surgery is desired. METHODS: This prospective randomized controlled study was conducted to enroll a total of 140 patients to evaluate the efficacy of low flow rate (1 L/min) for induction followed by high flow rate (10 L/min) for maintaining 12 mmHg pneumoperitoneum (group A, n = 70) during laparoscopic cholecystectomy (LC), compared to the continuous high flow rate group (group B, n = 70) in postoperative shoulder pain and other clinical features. The 10-visual analog scale (VAS) was applied for the severity of shoulder pain and scores were obtained at 1, 6, 12, 24, and 48 h after LC. RESULTS: There was no obvious difference in baseline characteristics as well as operative time, occurrence of bradycardia, or hospital stay between groups. The incidence of shoulder pain was not significantly different (group A 45.7% vs group B 48.6%, p = 0.866). However, the patients in group A with shoulder pain reported significantly less pain scores (p < 0.001) at 12 and 24 h after surgery, compared with those in group B. CONCLUSIONS: Applying the strategy of low flow rate to induce pneumoperitoneum followed by high flow rate to maintain the pressure provides advantages to reduce the severity of shoulder pain for patients who underwent LC and then experienced shoulder pain.


Subject(s)
Cholecystectomy, Laparoscopic/adverse effects , Insufflation/methods , Pain, Postoperative/prevention & control , Pneumoperitoneum, Artificial/adverse effects , Shoulder Pain/prevention & control , Adult , Aged , Cholecystectomy, Laparoscopic/methods , Female , Humans , Male , Middle Aged , Pain, Postoperative/etiology , Prospective Studies , Shoulder Pain/etiology , Visual Analog Scale
19.
Respirology ; 13(7): 1091-2, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18657063

ABSTRACT

Fistula formation between the bronchi and peritoneal cavity is extremely rare. In previous reports, fistulas have occurred secondary to thoraco-abdominal trauma, subphrenic abscess, suppurative biliary tract obstruction, malignancy and iatrogenically through procedures such as biliary surgery or percutaneous biliary drainage. The direction of fistula formation has always been thought to be from the peritoneal cavity to the bronchi: there are no reports of a fistula with a bronchial origin. This case report presents a patient who presented with sepsis and a bronchoperitoneal fistula and pneumoperitoneum secondary to lung abscess.


Subject(s)
Bronchial Fistula/etiology , Lung Abscess/complications , Peritoneal Diseases/etiology , Adult , Anti-Bacterial Agents/therapeutic use , Bronchial Fistula/diagnosis , Bronchial Fistula/surgery , Chest Tubes , Diagnosis, Differential , Drainage/instrumentation , Escherichia coli/isolation & purification , Escherichia coli Infections/complications , Escherichia coli Infections/diagnosis , Escherichia coli Infections/therapy , Fistula/diagnosis , Fistula/etiology , Fistula/surgery , Follow-Up Studies , Humans , Klebsiella Infections/complications , Klebsiella Infections/diagnosis , Klebsiella Infections/therapy , Klebsiella pneumoniae/isolation & purification , Laparotomy/methods , Lung Abscess/diagnosis , Lung Abscess/therapy , Male , Peritoneal Diseases/diagnosis , Peritoneal Diseases/surgery , Tomography, X-Ray Computed
20.
Am J Med Sci ; 335(5): 387-9, 2008 May.
Article in English | MEDLINE | ID: mdl-18480657

ABSTRACT

Immune reconstitution inflammatory syndrome (IRIS) is particularly observed after the start of therapy for pathogenic antigens in patients infected with human immunodeficiency virus (HIV) and receiving highly active antiretroviral therapy (HAART). Although tuberculosis (TB)-associated IRIS is the most common form, its presentation as a primary feature of acute peritonitis is extraordinarily rare. We report a 43-year-old man diagnosed with acquired immunodeficiency syndrome and pulmonary TB coinfection. His symptoms, sputum quantity, and chest radiologic appearance improved markedly after 3 weeks of antituberculous therapy, and HAART was initiated on the fourth week. However, acute abdomen with peritoneal signs resulting from the established tuberculous peritonitis developed on the seventh day of HAART. His clinical symptoms resolved after maintenance of HAART and antituberculous regimens. Tuberculous peritonitis must be considered in the differential diagnosis of acute abdomen in HIV-infected patients on antiviral therapy, especially in patients with known underlying TB. Early recognition of IRIS is important when managing HIV-infected patients with opportunistic infections.


Subject(s)
AIDS-Related Opportunistic Infections/complications , Antiretroviral Therapy, Highly Active/adverse effects , Peritonitis/etiology , Systemic Inflammatory Response Syndrome/etiology , Tuberculosis/complications , AIDS-Related Opportunistic Infections/immunology , Acute Disease , Adult , HIV Infections/drug therapy , Humans , Male , Tuberculosis/immunology
SELECTION OF CITATIONS
SEARCH DETAIL